• AMEDIPLASE CHEMBL2108361

    Alternate Names:

    Amediplase
    151912-11-7
    (3S,4S,12S,13S)-3,4,12,13-TETRAHYDRONAPHTHO[1,2-B]PHENANTHRENE-3,4,12,13-TETROL
    CID154656
    LS-189263
    151910-75-7
    3108
    CCRIS 8205
    TRANS,TRANS-3,4:12,13-TETRAHYDROXY-3,4,12,13-TETRAHYDRO-DIBENZ(A,H)ANTHRACENE
    AMEDIPLASE [INN]
    AC1L4CPU
    DCL000691
    3817181
    (7S,8S,21S,22S)-PENTACYCLO[12.8.0.0(3),(1)(2).0?,?.0(1)?,(2)?]DOCOSA-1,3,5,9,11,13,15,17,19-NONAENE-7,8,21,22-TETROL
    (3,4,12,13-TETRAHYDRODIBENZ[A,H]ANTHRACENE)-3ALPHA,4BETA,12ALPHA,13BETA-TETROL
    PL046849
    154656

    Drug Info:

    FDA Approval not approved
    Drug Class fusion protein
    Drug Indications antithrombotic
    (0 More Sources)

    Publications:

  • Interaction Types:
    activator

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name amediplase, K2tu-PA
    Novel drug target Established target

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antithrombotic
    Drug Class fusion protein
    FDA Approval not approved

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    3817181 Pubchem SId
    AMEDIPLASE Primary Drug Name
    151912-11-7 CAS Number

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    CCRIS 8205 pubchem_primary_name
    154656 PubChem CID
    AC1L4CPU Drug Synonym

    Drug Info:

    Publications: